Dr. Reddy's Laboratories Limited - Financial Analysis Review
Summary
Dr. Reddy’s Laboratories Limited (RL) is a leading pharmaceutical company. The company operates through four reportable business segments namely Formulations Segment, Active Pharmaceutical Ingredients and Intermediates Segment, Generics Segment, Drug Discovery Segment and Custom Pharmaceutical Services Segment. It serves the medical needs of the individuals through the API component of PSAI and the Global Generics business. It provides innovative products which solve unmet medical needs through the CPS component of PSAI and the Proprietary Products Businesses. The company has 36 subsidiaries and its wholly-owned subsidiaries are located in the US, UK, Russia, Germany and Brazil.
Global Markets Direct’s "Dr. Reddy's Laboratories Limited - Financial Analysis Review” is an in-depth business and financial analysis of Dr. Reddy's Laboratories Limited. The report provides a comprehensive insight into the company, including business structure and operations, executive biographies and key competitors. The hallmark of the report is the financial analysis of the company. This highlights the company’s ratio analysis for the past five years.
And More inside the report…
Recent Developments
Jan 04, 2010: Dr. Reddy's, Rheoscience Report Phase III Trial Results For Balaglitazone
Dec 15, 2009: Dr. Reddy’s Signs MoU With State of Louisiana
Sep 23, 2009: GSK Plans Expansion In India
Scope
- Provides key company information for business intelligence needs
- The report contains critical company information – business structure and operations, the company history, major products and services, key competitors, key employees and executive biographies, different locations and important subsidiaries.
- The report provides detailed financial ratios for the past five years as well as interim ratios for the last fourinterim periods.
- Financial ratios include profitability, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Reasons to buy
- A quick “one-stop-shop” to understand the company.
- Enhance business/sales activities by understanding customers’ businesses better.
- Get detailed information and financial analysis on companies operating in your industry.
- Identify prospective partners and suppliers – with key data on their businesses and locations.
- Compare your company’s financial trends with those of your peers / competitors.
- Scout for potential acquisition targets, with insight into the companies’ financial performance.
Report Highlights
The following companies are the major competitors of Dr. Reddy's Laboratories Limited:
Divis Laboratories Limited
Torrent Pharmaceuticals Limited
Berlin Chemi AG
Hetero Drugs Limited
[Studien Infos ausblenden]
